Geno J Germano
CIK 1424383 · President · last filed 2026-06-05
Geno J Germano is a President who has filed 96 SEC Form 4 insider transactions across 12 companies since 2008. The most recent filing, for DTIL, was dated Jun 5, 2026. Across all open-market trades the lifetime net is −$1.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $10.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$10.35M
12
96
-$1.07M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DTIL | Director | 44,883 | $6.10 | $273.8K | $47.6K | 12 | 2026-06-05 |
| HRMY | Director | — | $34.46 | — | $0 | 1 | 2026-05-18 |
| ENTX | Director | 40,000 | $1.23 | $49.2K | $55.8K | 2 | 2026-03-11 |
| Sage Therapeutics, Inc. (SAGE) Delisted | Director | — | $8.68 | — | $0 | 12 | 2025-07-31 |
| MEDICINES CO /DE (MDCO) Delisted | Director | 0 | — | — | $0 | 4 | 2020-01-06 |
| Bioverativ Inc. (BIVV) Delisted | Director | — | — | — | $0 | 3 | 2018-03-08 |
| PRECIGEN, INC. (XON) Delisted | President | — | — | — | $0 | 3 | 2016-09-26 |
| PFE | Group President | 367,537 | $26.21 | $9.63M | -$1.12M | 49 | 2015-02-27 |
| PFIZER INC (PFE.WD) Delisted | Business Unit President | 227,457 | — | — | $0 | 2 | 2013-06-28 |
| ZTS | Director | 5,000 | $79.57 | $397.8K | $130.0K | 1 | 2013-02-08 |
| WYETH (WYEp.CL) Delisted | Pres.-US Pharm. & Wom. Health. | 44,893 | — | — | $0 | 1 | 2009-04-29 |
| WYETH (WYEp) Delisted | Pres.-US Pharm. & Wom. Health. | 46,357 | — | — | -$179.4K | 5 | 2009-03-03 |
Recent Filings
96 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | DTIL | Grant (A) | — | $0 | EDGAR |
| 2026-05-22 | DTIL | Exer (M) | +21,000 | $0 | EDGAR |
| 2026-05-18 | HRMY | Grant (A) | — | $0 | EDGAR |
| 2026-03-11 | ENTX | Buy (P) | +20,000 | $26.0K | EDGAR |
| 2026-02-11 | ENTX | Buy (P) | +20,000 | $29.8K | EDGAR |
| 2025-12-17 | DTIL | Buy (P) | +3,000 | $14.2K | EDGAR |
| 2025-07-31 | Sage Therapeutics, Inc. (SAGE) Delisted | Disp (D) | — | $0 | EDGAR |
| 2025-06-13 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-06-04 | DTIL | Mixed | +9,826 | $0 | EDGAR |
| 2025-03-27 | DTIL | Buy (P) | +3,250 | $17.2K | EDGAR |